drugset / Trial / NCT00053508
Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to examine the safety and the effectiveness of a new vaccine for the prevention of the disease, smallpox.
Timeline
- Start
- 2002-09
- Primary completion
- 2003-03
- Completion
- 2003-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACAM1000 | Vaccine | 14000 unknown | — |
| Subject | ACAM1000 | Vaccine | 70000 unknown | — |
| Subject | ACAM1000 | Vaccine | 350000 unknown | — |
| Comparator | Dryvax | Vaccine | 250000 unknown | — |